Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.2986
+0.0139 (4.88%)
At close: Nov 4, 2026, 4:00 PM EST
0.2941
-0.0045 (-1.51%)
After-hours: Nov 4, 2026, 6:55 PM EST
Heron Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 37.67 | 34.71 | 40.59 | 38.21 | 37.2 | 38.9 | 40.78 | 32.81 | 36.02 | 34.67 | 34.23 | 31.43 | 31.76 | 29.62 | 30.03 | 26.56 | 27.63 | 23.46 | 20.66 | 23.23 | |
Revenue Growth (YoY) | 1.25% | -10.78% | -0.47% | 16.47% | 3.26% | 12.21% | 19.13% | 4.38% | 13.42% | 17.07% | 14.00% | 18.36% | 14.95% | 26.25% | 45.38% | 14.32% | 23.11% | 17.18% | 0.24% | 16.35% |
Cost of Revenue | 14.27 | 13.02 | 14.87 | 15.38 | 12.79 | 10.74 | 13.41 | 13.92 | 14.95 | 13.05 | 13.69 | 27.49 | 33.37 | 25.69 | 19.48 | 40.26 | 45.01 | 53.43 | 38.62 | 39.95 |
Gross Profit | 23.39 | 21.69 | 25.72 | 22.83 | 24.41 | 28.17 | 27.38 | 18.89 | 21.07 | 21.62 | 20.55 | 3.94 | -1.61 | 3.93 | 10.54 | -13.71 | -17.38 | -29.97 | -17.96 | -16.72 |
Selling, General & Admin | 25.44 | 26.45 | 25.69 | 26.92 | 26.05 | 25.01 | 23.2 | 23.35 | 27.52 | 26.42 | 13.17 | 28.87 | 40.8 | 36.99 | 25.5 | 28.18 | 32.12 | 32.96 | 34.17 | 34.99 |
Operating Expenses | 25.44 | 26.45 | 25.69 | 26.92 | 26.05 | 25.01 | 23.2 | 23.35 | 27.52 | 26.42 | 13.17 | 28.87 | 40.8 | 36.99 | 25.5 | 28.18 | 32.12 | 32.96 | 34.17 | 34.99 |
Operating Income | -2.04 | -4.77 | 0.04 | -4.09 | -1.64 | 3.15 | 4.17 | -4.46 | -6.45 | -4.8 | 7.38 | -24.93 | -42.4 | -33.06 | -14.96 | -41.88 | -49.5 | -62.92 | -52.14 | -51.71 |
Interest Expense | -3.8 | -3.2 | -3.71 | -2.9 | -1.5 | -0.9 | -1.53 | -1.5 | -1.4 | -0.9 | -2.07 | -0.6 | -0.6 | -0.6 | -0.67 | -0.61 | -0.61 | -0.61 | -0.57 | -0.61 |
Interest & Investment Income | - | - | 1.95 | - | - | - | 3.55 | - | - | - | 3.36 | - | - | - | 1.64 | - | - | - | 0.43 | - |
Other Non Operating Income (Expenses) | 0.36 | -0.15 | -0.82 | 0.84 | 0.76 | 0.38 | -0.62 | 1.11 | -1.39 | 2.54 | -1.18 | 0.52 | 0.94 | 0.9 | -0.27 | 0.59 | -6.25 | -0.35 | -0.5 | -0.09 |
EBT Excluding Unusual Items | -5.49 | -8.11 | -2.54 | -6.16 | -2.38 | 2.64 | 5.57 | -4.85 | -9.24 | -3.16 | 7.49 | -25.01 | -42.06 | -32.77 | -14.26 | -41.91 | -56.36 | -63.89 | -52.77 | -52.41 |
Merger & Restructuring Charges | - | - | - | - | - | - | - | - | - | - | -4.2 | - | - | - | -5.4 | - | - | - | -1.4 | - |
Gain (Loss) on Sale of Investments | - | - | - | - | - | - | 0.01 | - | - | - | -0 | - | - | - | - | - | - | - | - | - |
Asset Writedown | - | - | -0.41 | - | - | - | -1.91 | - | - | - | -0.62 | - | - | - | -0.21 | - | - | - | -0.48 | - |
Other Unusual Items | - | - | - | -11.34 | - | - | - | - | - | - | -13.4 | - | - | - | - | - | - | - | - | - |
Pretax Income | -5.49 | -8.11 | -2.95 | -17.5 | -2.38 | 2.64 | 3.66 | -4.85 | -9.24 | -3.16 | -10.72 | -25.01 | -42.06 | -32.77 | -19.87 | -41.91 | -56.36 | -63.89 | -54.65 | -52.41 |
Net Income | -5.49 | -8.11 | -2.95 | -17.5 | -2.38 | 2.64 | 3.66 | -4.85 | -9.24 | -3.16 | -10.72 | -25.01 | -42.06 | -32.77 | -19.87 | -41.91 | -56.36 | -63.89 | -54.65 | -52.41 |
Net Income to Common | -5.49 | -8.11 | -2.95 | -17.5 | -2.38 | 2.64 | 3.66 | -4.85 | -9.24 | -3.16 | -10.72 | -25.01 | -42.06 | -32.77 | -19.87 | -41.91 | -56.36 | -63.89 | -54.65 | -52.41 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 190 | 190 | 188 | 170 | 154 | 153 | 153 | 153 | 152 | 151 | 153 | 145 | 120 | 119 | 117 | 112 | 102 | 102 | 102 | 102 |
Shares Outstanding (Diluted) | 190 | 190 | 188 | 170 | 154 | 197 | 153 | 153 | 152 | 151 | 153 | 145 | 120 | 119 | 117 | 112 | 102 | 102 | 102 | 102 |
Shares Change (YoY) | 23.58% | -3.69% | 22.78% | 11.46% | 1.13% | 30.24% | -0.03% | 5.41% | 27.22% | 26.80% | 31.08% | 29.76% | 16.91% | 16.77% | 14.61% | 9.64% | 4.01% | 11.75% | 11.96% | 12.17% |
EPS (Basic) | -0.03 | -0.04 | -0.02 | -0.10 | -0.02 | 0.02 | 0.02 | -0.03 | -0.06 | -0.02 | -0.07 | -0.17 | -0.35 | -0.27 | -0.17 | -0.38 | -0.55 | -0.63 | -0.54 | -0.51 |
EPS (Diluted) | -0.03 | -0.04 | -0.02 | -0.10 | -0.02 | 0.01 | 0.02 | -0.03 | -0.06 | -0.02 | -0.07 | -0.17 | -0.35 | -0.27 | -0.17 | -0.38 | -0.55 | -0.63 | -0.54 | -0.51 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -2.35 | -1.93 | -9.18 | 1.33 | -11.08 | -8.98 | -12.42 | 2.94 | -5.24 | -9.52 | 2.21 | -9.97 | -27.44 | -25.12 | -37.95 | -37.11 | -28.7 | -44.98 | -45.65 | -54.7 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.05 | 0.01 | -0.07 | -0.05 | -0.08 | 0.02 | -0.03 | -0.06 | 0.01 | -0.07 | -0.23 | -0.21 | -0.33 | -0.33 | -0.28 | -0.44 | -0.45 | -0.54 |
Gross Margin | 62.10% | 62.48% | 63.38% | 59.74% | 65.62% | 72.40% | 67.13% | 57.56% | 58.50% | 62.35% | 60.02% | 12.54% | -5.06% | 13.25% | 35.11% | -51.61% | -62.90% | -127.76% | -86.97% | -71.96% |
Operating Margin | -5.43% | -13.73% | 0.09% | -10.71% | -4.40% | 8.11% | 10.23% | -13.59% | -17.89% | -13.84% | 21.56% | -79.31% | -133.50% | -111.64% | -49.80% | -157.71% | -179.15% | -268.25% | -252.42% | -222.59% |
Profit Margin | -14.57% | -23.37% | -7.28% | -45.78% | -6.40% | 6.77% | 8.98% | -14.78% | -25.64% | -9.12% | -31.33% | -79.56% | -132.42% | -110.65% | -66.17% | -157.80% | -203.98% | -272.36% | -264.56% | -225.61% |
Free Cash Flow Margin | -6.24% | -5.56% | -22.63% | 3.48% | -29.77% | -23.08% | -30.45% | 8.96% | -14.55% | -27.45% | 6.44% | -31.72% | -86.40% | -84.84% | -126.38% | -139.74% | -103.86% | -191.77% | -221.00% | -235.46% |
EBITDA | -1.59 | -4.24 | 0.58 | -3.48 | -1.03 | 3.71 | 4.75 | -3.88 | -5.8 | -4.11 | 8.1 | -24.2 | -41.66 | -32.35 | -14.16 | -41.18 | -48.83 | -62.2 | -51.34 | -50.95 |
EBITDA Margin | -4.23% | -12.20% | 1.42% | -9.10% | -2.76% | 9.52% | 11.66% | -11.82% | -16.11% | -11.85% | 23.65% | -76.99% | -131.18% | -109.22% | -47.17% | -155.05% | -176.72% | -265.17% | -248.57% | -219.35% |
D&A For EBITDA | 0.45 | 0.53 | 0.54 | 0.62 | 0.61 | 0.55 | 0.58 | 0.58 | 0.64 | 0.69 | 0.72 | 0.73 | 0.74 | 0.72 | 0.79 | 0.71 | 0.67 | 0.72 | 0.79 | 0.75 |
EBIT | -2.04 | -4.77 | 0.04 | -4.09 | -1.64 | 3.15 | 4.17 | -4.46 | -6.45 | -4.8 | 7.38 | -24.93 | -42.4 | -33.06 | -14.96 | -41.88 | -49.5 | -62.92 | -52.14 | -51.71 |
EBIT Margin | -5.43% | -13.73% | 0.09% | -10.71% | -4.40% | 8.11% | 10.23% | -13.59% | -17.89% | -13.84% | 21.56% | -79.31% | -133.50% | -111.64% | -49.80% | -157.71% | -179.15% | -268.25% | -252.42% | -222.59% |